🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emmanuel Ndashimye

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0002-9112-9402
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.

20 citations

Mariano Avino, Abayomi S. Olabode, Art F. Y. Poon, Richard M. Gibson, Yue Li +9 more

3 citations

Hannah O. Ajoge, Macon D. Coleman, Emmanuel Ndashimye, Richard M. Gibson, Eric J. Arts +2 more

N/A
0DataRank · unranked
19 citations

J Pankrac, Emmanuel Ndashimye, Jessica L. Prodger, Melissa-Rose Abrahams, Jamie F. S. Mann +3 more

18 citations

Yue Li, Paul S Reyes, Mariano Avino, Abayomi S. Olabode, Cissy Kityo +6 more

18 citations

Paul S Reyes, Eric J. Arts, Emmanuel Ndashimye

7 citations

Hannah O. Ajoge, Macon D. Coleman, Emmanuel Ndashimye, Richard M. Gibson, Eric J. Arts +2 more

6 citations

J Pankrac, Ryan C. Y. Ho, Emmanuel Ndashimye, Rahul Pawa, Renata Ceccacci +21 more